The resistance of a pacing lead negatively correlates to current consumptio
n. A prospective, randomized trial was conducted to evaluate the effect of
a high impedance ventricular lead (CapSure Z) on generator longevity compar
ed to a conventional lead (CapSure SP) eighty-nine patients were included i
n the study (51 male, 37 female, age 70.0 +/- 10.3 years). Forty-six patien
ts received a CapSure SP lead (5024 bipolar), and 43 patients received a Ca
pSure Z lead (5034 bipolar) in a randomized fashion. Follow-up data collect
ed at 5 days, 3, 6, and 12 months postimplant included: lead impedance, pac
ing and sensing thresholds, impulse energy, and estimated time to replaceme
nt. All parameters were collected via pacemaker telemetry the time to repla
cement was calculated automatically by a programmed algorithm of the pacema
ker. There was no difference in the performance of the atrial lead when a d
ual chamber device was indicated. The CapSure Z leads displayed statistical
ly significant higher impedance values than the CapSure SP lead in all foll
ow-up periods. There was no significant difference in lead related complica
tions. No significant differences were observed between pacing and sensing
thresholds in both groups. The CapSure Z leads provided a significant reduc
tion in current drain, resulting in a reduction of mean energy consumption
at the 12-month follow-up from 10.4 +/- 5.01 muJ in the CapSure SP group to
6.6 +/- 1.4 muJ in the CapSure Z group (median from 9.9 muJ to 6.9 muj, re
spectively), providing an estimated increase in mean longevity of more than
1 year from 81.1 +/- 13.5 months in the CapSure SP group to 94.5 +/- 13.4
months in the CapSure Z group (median: 76.5 months to 95.0 months, respecti
vely). The use of a high resistance lead for ventricular pacing appears to
result in a clinically relevant extension of generator longevity.